from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1948c/-

LFCtreatmentdescriptionclass of inhibitor

-0.054

Amikacinug/mL Amikacintranslation

-0.690

Cap5-10ug/mL Capreomycintranslation

0.277

Rox10-50 ug/mL Roxithromycintranslation

-0.319

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.229

Rif0.2-5ug/mL Rifampicintranscription

-0.226

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.260

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.775

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.183

CPZ10-50 ug/mL Chlorpromazinerespiration

0.010

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.568

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.509

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.982

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.156

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.426

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.230

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.545

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.268

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.890

KCN5-20 ug/mL Potassium cyaniderespiration

-1.072

NaN30.2-2 mM Sodium aziderespiration

1.570

Nigericin50 uM Nigericinrespiration

0.302

TRC10-150 ug/mL Triclosanrespiration

0.237

TRZ10-25 ug/mL Thioridazinerespiration

0.654

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.225

menadione6-10 ug/mL Menadionerespiration

-0.009

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.235

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.261

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.317

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.099

NRP_1Non-replicating persistence stage 1dosRassociated

0.629

Amp0.2mg/mL AmpicillincellWall

-0.187

Cephalexin20-100 ug/mL CephalexincellWall

0.967

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.412

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.483

EMB10-20 ug/mL EthambutolcellWall

-0.204

Eta12-40 ug/mL EthionamidecellWall

0.165

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.519

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.516

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.110

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.209

BZA0.12 mg/mL BenzamidearomaticAmides

0.210

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.030

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.619

H2O24 mM hydrogen peroxideDNAdamaging

-0.164

Levo10 ug/mL LevofloxacinDNAdamaging

0.350

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.732

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.419

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.279

UVUV-irradiationDNAdamaging

0.666

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.491

Antimycin12.5-50 ug/mL Antimycin A?

-0.395

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.637

PA_110-50 ug/mL Antitubercular compound PA-1?

0.174

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.400

PA8240.2-2 ug/mL PA-824?

-0.247

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.184

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.938

Verapamil50 uM Verapamil?

-0.498

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.944

methoxatin10-20 ug/mL Methoxatin?